Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells

O. G. Ottmann, K. H. Nocka, M. A S Moore, Louis Pelus

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Expression of major histocompatibility complex class II Ags HLA-DR, HLA-DP, and HLA-DQ on human BM granulocyte-erythroid-macrophage-megakaryocyte CFU (CFU-GEMM), BFU-E, and CFU-GM was examined by indirect immunofluorescence, cell sorting, and complement-mediated cytotoxicity. BM, highly enriched for progenitor cells by depletion of mature hematopoietic elements, was further separated by sterile sorting into HLA-DR (-), low, intermediate, and high intensity HLA-DR (+), as well as HLA-DP (+) and HLA-DP (-) cell fractions and assayed for progenitor cell content. In addition, in the case of HLA-DR, CFU-GM response to inhibition by prostaglandin E was determined. Cell sorting and cytotoxicity data confirm that approximately 95% of assayable erythroid, myeloid, and multipotential progenitor cells expressed HLA-DR, whereas HLA-DQ Ags were undetectable. HLA-DR and HLA-DP Ags were co-expressed on 61% of these progenitor cells, predominantly those expressing HLA-DR at high intensity. Day 7 and 14 CFU-GM showed a trend toward segregation to the high HLA-DR (+) cell fractions, especially when recombinant human G-CSF was used to stimulate clone formation. Both day 7 and day 14 CFU-GMs were found predominantly in the HLA-DP (+) cell fraction. In contrast, BFU-E and CFU-GEMM were found in the low intensity HLA-DR cell fraction and predominantly in the HLA-DP (-) fraction. Both eosinophils CFU and cells giving rise to basophil/mast cells in suspension culture were found in the low and intermediate intensity HLA-DR fractions, but could be segregated into HLA-DP (+) and HLA DP (-) cell fractions, respectively. Functional analysis on day 7 CFU-GM segregated, based upon HLA-DR intensity, indicated a positive correlation, between increasing HLA-DR intensity and responsiveness to inhibition by prostaglandin E. Furthermore, only those CFU-GM expressing HLA-DR at high intensity could be removed by cytolytic treatment using a mAb anti-HLA-DR previously shown to be selective for CFU-GM responsive to PGE and in S phase of the cell cycle.

Original languageEnglish (US)
Pages (from-to)677-686
Number of pages10
JournalLeukemia
Volume2
Issue number10
StatePublished - 1988
Externally publishedYes

Fingerprint

Histocompatibility Antigens Class II
HLA-DR Antigens
Hematopoietic Stem Cells
HLA-DP Antigens
Granulocyte-Macrophage Progenitor Cells
Myeloid Progenitor Cells
Prostaglandins E
HLA-DQ Antigens
Erythroid Precursor Cells
Stem Cells
Megakaryocytes
Basophils
Granulocyte Colony-Stimulating Factor
Indirect Fluorescent Antibody Technique
Major Histocompatibility Complex
S Phase
Granulocytes
Eosinophils
Mast Cells
Suspensions

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Ottmann, O. G., Nocka, K. H., Moore, M. A. S., & Pelus, L. (1988). Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells. Leukemia, 2(10), 677-686.

Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells. / Ottmann, O. G.; Nocka, K. H.; Moore, M. A S; Pelus, Louis.

In: Leukemia, Vol. 2, No. 10, 1988, p. 677-686.

Research output: Contribution to journalArticle

Ottmann, OG, Nocka, KH, Moore, MAS & Pelus, L 1988, 'Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells', Leukemia, vol. 2, no. 10, pp. 677-686.
Ottmann, O. G. ; Nocka, K. H. ; Moore, M. A S ; Pelus, Louis. / Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells. In: Leukemia. 1988 ; Vol. 2, No. 10. pp. 677-686.
@article{8808bc6f7b30419f82dba4867edcc069,
title = "Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells",
abstract = "Expression of major histocompatibility complex class II Ags HLA-DR, HLA-DP, and HLA-DQ on human BM granulocyte-erythroid-macrophage-megakaryocyte CFU (CFU-GEMM), BFU-E, and CFU-GM was examined by indirect immunofluorescence, cell sorting, and complement-mediated cytotoxicity. BM, highly enriched for progenitor cells by depletion of mature hematopoietic elements, was further separated by sterile sorting into HLA-DR (-), low, intermediate, and high intensity HLA-DR (+), as well as HLA-DP (+) and HLA-DP (-) cell fractions and assayed for progenitor cell content. In addition, in the case of HLA-DR, CFU-GM response to inhibition by prostaglandin E was determined. Cell sorting and cytotoxicity data confirm that approximately 95{\%} of assayable erythroid, myeloid, and multipotential progenitor cells expressed HLA-DR, whereas HLA-DQ Ags were undetectable. HLA-DR and HLA-DP Ags were co-expressed on 61{\%} of these progenitor cells, predominantly those expressing HLA-DR at high intensity. Day 7 and 14 CFU-GM showed a trend toward segregation to the high HLA-DR (+) cell fractions, especially when recombinant human G-CSF was used to stimulate clone formation. Both day 7 and day 14 CFU-GMs were found predominantly in the HLA-DP (+) cell fraction. In contrast, BFU-E and CFU-GEMM were found in the low intensity HLA-DR cell fraction and predominantly in the HLA-DP (-) fraction. Both eosinophils CFU and cells giving rise to basophil/mast cells in suspension culture were found in the low and intermediate intensity HLA-DR fractions, but could be segregated into HLA-DP (+) and HLA DP (-) cell fractions, respectively. Functional analysis on day 7 CFU-GM segregated, based upon HLA-DR intensity, indicated a positive correlation, between increasing HLA-DR intensity and responsiveness to inhibition by prostaglandin E. Furthermore, only those CFU-GM expressing HLA-DR at high intensity could be removed by cytolytic treatment using a mAb anti-HLA-DR previously shown to be selective for CFU-GM responsive to PGE and in S phase of the cell cycle.",
author = "Ottmann, {O. G.} and Nocka, {K. H.} and Moore, {M. A S} and Louis Pelus",
year = "1988",
language = "English (US)",
volume = "2",
pages = "677--686",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells

AU - Ottmann, O. G.

AU - Nocka, K. H.

AU - Moore, M. A S

AU - Pelus, Louis

PY - 1988

Y1 - 1988

N2 - Expression of major histocompatibility complex class II Ags HLA-DR, HLA-DP, and HLA-DQ on human BM granulocyte-erythroid-macrophage-megakaryocyte CFU (CFU-GEMM), BFU-E, and CFU-GM was examined by indirect immunofluorescence, cell sorting, and complement-mediated cytotoxicity. BM, highly enriched for progenitor cells by depletion of mature hematopoietic elements, was further separated by sterile sorting into HLA-DR (-), low, intermediate, and high intensity HLA-DR (+), as well as HLA-DP (+) and HLA-DP (-) cell fractions and assayed for progenitor cell content. In addition, in the case of HLA-DR, CFU-GM response to inhibition by prostaglandin E was determined. Cell sorting and cytotoxicity data confirm that approximately 95% of assayable erythroid, myeloid, and multipotential progenitor cells expressed HLA-DR, whereas HLA-DQ Ags were undetectable. HLA-DR and HLA-DP Ags were co-expressed on 61% of these progenitor cells, predominantly those expressing HLA-DR at high intensity. Day 7 and 14 CFU-GM showed a trend toward segregation to the high HLA-DR (+) cell fractions, especially when recombinant human G-CSF was used to stimulate clone formation. Both day 7 and day 14 CFU-GMs were found predominantly in the HLA-DP (+) cell fraction. In contrast, BFU-E and CFU-GEMM were found in the low intensity HLA-DR cell fraction and predominantly in the HLA-DP (-) fraction. Both eosinophils CFU and cells giving rise to basophil/mast cells in suspension culture were found in the low and intermediate intensity HLA-DR fractions, but could be segregated into HLA-DP (+) and HLA DP (-) cell fractions, respectively. Functional analysis on day 7 CFU-GM segregated, based upon HLA-DR intensity, indicated a positive correlation, between increasing HLA-DR intensity and responsiveness to inhibition by prostaglandin E. Furthermore, only those CFU-GM expressing HLA-DR at high intensity could be removed by cytolytic treatment using a mAb anti-HLA-DR previously shown to be selective for CFU-GM responsive to PGE and in S phase of the cell cycle.

AB - Expression of major histocompatibility complex class II Ags HLA-DR, HLA-DP, and HLA-DQ on human BM granulocyte-erythroid-macrophage-megakaryocyte CFU (CFU-GEMM), BFU-E, and CFU-GM was examined by indirect immunofluorescence, cell sorting, and complement-mediated cytotoxicity. BM, highly enriched for progenitor cells by depletion of mature hematopoietic elements, was further separated by sterile sorting into HLA-DR (-), low, intermediate, and high intensity HLA-DR (+), as well as HLA-DP (+) and HLA-DP (-) cell fractions and assayed for progenitor cell content. In addition, in the case of HLA-DR, CFU-GM response to inhibition by prostaglandin E was determined. Cell sorting and cytotoxicity data confirm that approximately 95% of assayable erythroid, myeloid, and multipotential progenitor cells expressed HLA-DR, whereas HLA-DQ Ags were undetectable. HLA-DR and HLA-DP Ags were co-expressed on 61% of these progenitor cells, predominantly those expressing HLA-DR at high intensity. Day 7 and 14 CFU-GM showed a trend toward segregation to the high HLA-DR (+) cell fractions, especially when recombinant human G-CSF was used to stimulate clone formation. Both day 7 and day 14 CFU-GMs were found predominantly in the HLA-DP (+) cell fraction. In contrast, BFU-E and CFU-GEMM were found in the low intensity HLA-DR cell fraction and predominantly in the HLA-DP (-) fraction. Both eosinophils CFU and cells giving rise to basophil/mast cells in suspension culture were found in the low and intermediate intensity HLA-DR fractions, but could be segregated into HLA-DP (+) and HLA DP (-) cell fractions, respectively. Functional analysis on day 7 CFU-GM segregated, based upon HLA-DR intensity, indicated a positive correlation, between increasing HLA-DR intensity and responsiveness to inhibition by prostaglandin E. Furthermore, only those CFU-GM expressing HLA-DR at high intensity could be removed by cytolytic treatment using a mAb anti-HLA-DR previously shown to be selective for CFU-GM responsive to PGE and in S phase of the cell cycle.

UR - http://www.scopus.com/inward/record.url?scp=0023696016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023696016&partnerID=8YFLogxK

M3 - Article

C2 - 3172844

AN - SCOPUS:0023696016

VL - 2

SP - 677

EP - 686

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 10

ER -